Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2205728 | 0.67 | LMNA (0.59) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL14297683 | 0.67 | LMNA (0.59) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL6456004 | 0.63 | LMNA (0.46) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL2235435 | 0.63 | LMNA (0.53) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL10752491 | 0.63 | LMNA (0.53) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL351958 | 0.62 | LMNA (0.38) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL351471 | 0.62 | LMNA (0.38) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL2267086 | 0.62 | LMNA (0.38) | LMNACYP1A2THRBBLMCREBBP | |
| Altretamine SCHEMBL2354769 | 0.61 | LMNA (1.00) | LMNACYP1A2THRBBLMCREBBP | |
| Altretamine SCHEMBL4206 | 0.61 | LMNA (1.00) | LMNACYP1A2THRBBLMCREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140162906-A1 | Pesticide Biomarker | NAGY JON OWEN (US) | 2014-06-12 | — | — | US | disclosed |
| US-20110166043-A1 | BIOMARKER DETECTION-2 | ATERIS TECHNOLOGIES, LLC | 2011-07-07 | — | — | US | disclosed |
| US-20100041077-A1 | PESTICIDE BIOMARKER | ATERIS TECHNOLOGIES, LLC | 2010-02-18 | — | — | US | disclosed |
| EP-0906014-B1 | Shaped bodies which release agrochemicals | BAYER AG (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-6329419-B1 | CHLORFENAPYR AND SYNERGISTIC AMOUNT OF SUBSTITUTED PHENYLMETHYLCARBAMATE COMPOUND SUCH AS FENOBUCARB, ETHIOFENCARB, ISOPROCARB, METOLCARB, XYLYLCARB, PROPOXUR, CARBARYL, 3,5-XYLYLMETHYCARBAMATE, AND BENDIOCARB | AMERICAN CYANAMID CO. | 2001-12-11 | — | — | US | disclosed |
| CN-1044233-C | Amide compounds and their salts, processes for their production and pesticidal compositions containing them | ISHIHARA SANGYO KAISHA (JP) | 1999-07-21 | — | — | CN | disclosed |
| CN-1081670-A | Amide compound and salt thereof, their manufacturing process and pesticide composition thereof | ISHIHARA SANGYO KAISHA (JP) | 1994-02-09 | — | — | CN | disclosed |
| EP-0505378-A1 | DELIVERY SYSTEM FOR AGRICULTURAL CHEMICALS | ISP INVESTMENTS INC. (US) | 1992-09-30 | — | — | EP | disclosed |
| EP-0205049-A1 | N-benzoyl-N'-(1,1-difluoro-phenylmethyl)-phenyl ureas, processes for their production and their use in pest control | BASF Aktiengesellschaft (DE) | 1986-12-17 | — | — | EP | disclosed |
| EP-0124404-A1 | Insecticide collar and method for its manufacture | Rombi, Max André (FR) | 1984-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166043-A1 | BIOMARKER DETECTION-2 | CPB2, NAALAD2, PRSS2 | LMNA 4505/4885CYP1A2 273/4885THRB 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.